FTSE 100 slumped at the open after a dip in Asian markets overnight and ahead of the Jackson Hole meeting of central bankers in the US. London’s leading index tumbled 52 points to 7,097 in early trading.
The NHS is the latest UK organisation to be impacted by supply chain issues. Clinics have stopped some blood testing for certain conditions because there aren’t enough vials.
Property giant British Land (LSE:BLND) continues to review its portfolio, having sold or received offers for roughly £160mln of assets in the current quarter. Prices are 6% ahead of book value it added.
Time’s up for Rank Group (LSE:RNK) (LON:RNK) CFO, Bill Floydd, who is leaving the Grosvenor Casinos owner after 18 months in the role. He is off to Watches of Switzerland.
MGC Pharma PLC (LON:MXC, ASX:MXC) shares rocketed as it signed a landmark deal with an American drug distributor worth a minimum US$24mln over the next three years. The tie-up with AMC Holdings will see MGC supplying the phytomedicine products CannEpil, CogniCann and CimetrA for use in clinical trials.
Helium One Global Ltd (AIM:HE1) (AIM:HE1) has declared its 2021 drill campaign over, with the Tai-2 well completing without identifying helium gas. The two wells drilled in the campaign leave the explorer with a ‘proven’ working helium system, with beneficial packages of geological data, but not with material discoveries of helium.
Scancell Holdings PLC (AIM:SCLP, FRA:SCP) (AIM:SCLP, FRA:SCP) (LON:SCLP) says the UK's Medicines and Healthcare Products Regulatory Authority has approved the clinical trial application (CTA) for a phase I/II clinical study of Modi-1, the company’s cancer vaccine candidate. Patient enrolment should take place in the second half of this year.